Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1993 1
1994 1
1995 5
1996 9
1997 5
1998 8
1999 6
2000 4
2001 3
2002 1
2003 6
2004 4
2005 3
2007 3
2008 7
2009 4
2010 1
2011 1
2012 4
2013 3
2014 2
2015 5
2016 2
2017 3
2018 3
2019 5
2020 5
2024 2
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Results by year

Filters applied: . Clear all
Page 1
Estimating the effect size of the 15Q11.2 BP1-BP2 deletion and its contribution to neurodevelopmental symptoms: recommendations for practice.
Jønch AE, Douard E, Moreau C, Van Dijck A, Passeggeri M, Kooy F, Puechberty J, Campbell C, Sanlaville D, Lefroy H, Richetin S, Pain A, Geneviève D, Kini U, Le Caignec C, Lespinasse J, Skytte AB, Isidor B, Zweier C, Caberg JH, Delrue MA, Møller RS, Bojesen A, Hjalgrim H, Brasch-Andersen C, Lemyre E, Ousager LB, Jacquemont S; 15q11.2 Working Group. Jønch AE, et al. J Med Genet. 2019 Oct;56(10):701-710. doi: 10.1136/jmedgenet-2018-105879. Epub 2019 Aug 26. J Med Genet. 2019. PMID: 31451536 Free PMC article.
Case-control studies have associated the 15q11.2 deletion with neurodevelopmental disorders, and clinical case series have attempted to delineate a microdeletion syndrome with considerable phenotypic variability. ...The estimated ORs and respective frequencies in deletion …
Case-control studies have associated the 15q11.2 deletion with neurodevelopmental disorders, and clinical case series have attempted …
The neurophysiological brain-fingerprint of Parkinson's disease.
da Silva Castanheira J, Wiesman AI, Hansen JY, Misic B, Baillet S; PREVENT-AD Research Group; Quebec Parkinson Network. da Silva Castanheira J, et al. EBioMedicine. 2024 Jul;105:105201. doi: 10.1016/j.ebiom.2024.105201. Epub 2024 Jun 21. EBioMedicine. 2024. PMID: 38908100 Free PMC article.
Furthermore, our study reveals that the cortical topography of the Parkinson's brain-fingerprint aligns with that of neurotransmitter systems affected by the disease's pathophysiology. ...We outline patient-specific rhythmic brain signaling features that prov …
Furthermore, our study reveals that the cortical topography of the Parkinson's brain-fingerprint aligns with that of neurotran …
Associations between neuromelanin depletion and cortical rhythmic activity in Parkinson's disease.
Wiesman AI, Madge V, Fon EA, Dagher A, Collins DL, Baillet S; PREVENT-AD Research Group and Quebec Parkinson Network. Wiesman AI, et al. Brain. 2025 Mar 6;148(3):875-885. doi: 10.1093/brain/awae295. Brain. 2025. PMID: 39282945 Free PMC article.
Parkinson's disease (PD) is marked by the death of neuromelanin-rich dopaminergic and noradrenergic cells in the substantia nigra (SN) and the locus coeruleus (LC), respectively, resulting in motor and cognitive impairments. Although SN dopamine dysfun …
Parkinson's disease (PD) is marked by the death of neuromelanin-rich dopaminergic and noradrenergic cells in the substa …
Gender and funding success.
Appel-Cresswell S, Blanchet PJ, Wysocki J, Postuma RB. Appel-Cresswell S, et al. Among authors: blanchet pj. Lancet. 2019 Jun 1;393(10187):2195-2196. doi: 10.1016/S0140-6736(19)31107-9. Lancet. 2019. PMID: 31162073 No abstract available.
Oral dyskinesia: a clinical overview.
Blanchet PJ, Rompré PH, Lavigne GJ, Lamarche C. Blanchet PJ, et al. Int J Prosthodont. 2005 Jan-Feb;18(1):10-9. Int J Prosthodont. 2005. PMID: 15754887 Review.
The main findings of a field study on oral dyskinesia were also reviewed. RESULTS: Involuntary movement disorders are often drug related. ...CONCLUSION: A multidisciplinary evaluation is desirable in the care of individuals with oral dyskinesia and in the sel …
The main findings of a field study on oral dyskinesia were also reviewed. RESULTS: Involuntary movement disorders are often dr …
A Focused Update on Tardive Dyskinesia.
Blanchet PJ. Blanchet PJ. Can J Neurol Sci. 2020 Nov;47(6):747-755. doi: 10.1017/cjn.2020.131. Epub 2020 Jul 6. Can J Neurol Sci. 2020. PMID: 32624027
Tardive dyskinesia (TD) is a delayed and potentially irreversible motor complication following chronic exposure to centrally acting dopamine receptor antagonists, mainly of the class of antipsychotics drugs. ...Protocol variations between experimental laborat …
Tardive dyskinesia (TD) is a delayed and potentially irreversible motor complication following chronic exposure to centrally acting …
Proton magnetic resonance spectroscopy study of dyskinesia patients.
Kuznetsov Y, Khiat A, Blanchet PJ, Boulanger Y. Kuznetsov Y, et al. Among authors: blanchet pj. Mov Disord. 2007 May 15;22(7):957-62. doi: 10.1002/mds.21459. Mov Disord. 2007. PMID: 17377925
Oral dyskinesias may occur spontaneously or be induced by medications such as antipsychotics and antidepressants. In this study, single voxel proton magnetic resonance spectroscopy was used to compare metabolite levels in the striatum for (1) 12 patients with drug-i …
Oral dyskinesias may occur spontaneously or be induced by medications such as antipsychotics and antidepressants. In this stud …
Chronic pain and pain processing in Parkinson's disease.
Blanchet PJ, Brefel-Courbon C. Blanchet PJ, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2018 Dec 20;87(Pt B):200-206. doi: 10.1016/j.pnpbp.2017.10.010. Epub 2017 Oct 12. Prog Neuropsychopharmacol Biol Psychiatry. 2018. PMID: 29031913 Review.
Pain is experienced by the vast majority of patients living with Parkinson's disease. It is most often of nociceptive origin, but may also be ascribed to neuropathic (radicular or central) or miscellaneous sources. ...In Parkinson's disease …
Pain is experienced by the vast majority of patients living with Parkinson's disease. It is most often of nociceptive o …
In memoriam: Paul J. Bedard, MD PhD (1942-2014).
Di Paolo T, Blanchet PJ. Di Paolo T, et al. Among authors: blanchet pj. Parkinsonism Relat Disord. 2015 May;21(5):429. doi: 10.1016/j.parkreldis.2015.01.014. Epub 2015 Jan 31. Parkinsonism Relat Disord. 2015. PMID: 25737206 No abstract available.
Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine.
Morissette M, Goulet M, Calon F, Falardeau P, Blanchet PJ, Bédard PJ, Di Paolo T. Morissette M, et al. Among authors: blanchet pj. Mol Pharmacol. 1996 Nov;50(5):1073-9. Mol Pharmacol. 1996. PMID: 8913337
The effect of L-3,4-dihydroxyphenylalanine (L-DOPA) on dopamine receptor gene expression in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned monkeys was investigated using in situ hybridization histochemistry with measures of changes in relative ab …
The effect of L-3,4-dihydroxyphenylalanine (L-DOPA) on dopamine receptor gene expression in the brain of 1-methyl-4-phenyl-1,2,3,6-te …
102 results